Who owns the CRISPR BY DESIGN trademark?

The CRISPR BY DESIGN trademark is owned by Scribe Therapeutics Inc..

What class is the CRISPR BY DESIGN trademark registered in?

The CRISPR BY DESIGN trademark is registered in Class 042 (Scientific, technology & SaaS services).

What is the serial number for CRISPR BY DESIGN?

The USPTO serial number for CRISPR BY DESIGN is 90981354.

What is the registration number for CRISPR BY DESIGN?

CRISPR BY DESIGN is registered under USPTO registration number 7689563.

Sealvo

Home Search: CRISPR BY DESIGNCRISPR BY DESIGN #90981354

Back

Updated Sep 30, 2026·42 searches this week

View on USPTO TSDR Find similar marks

CRI

USPTO Trademark Record

REGISTERED

CRISPR BY DESIGN

SN 90981354·Reg 7689563·Filed Mar 23, 2021

Owner Scribe Therapeutics Inc.

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

CRISPR BY DESIGN (Serial No. 90981354), Registration No. 7689563, is a registered US trademark filed on Mar 23, 2021 by Scribe Therapeutics Inc.. This trademark covers Class 042 (Scientific, technology & SaaS services).

early section 8: February 11, 2031

Conflict Analysis

Full conflict analysis for CRISPR BY DESIGN (SN 90981354) against the USPTO database with detailed risk factor explanations. AI-powered — takes ~1-2 min.

Mark Intelligence

CRISPR BY DESIGN (Reg. #7689563) is a registered US trademark that has been protecting its owner, Scribe Therapeutics Inc., since 2021. The mark covers Class 042 (Scientific, technology & SaaS services). Goods and services include Scientific and technological services and research and design relating thereto; industrial analysis, industrial research.... The mark faced 1 opposition proceeding during prosecution.

FILED

Mar 23, 2021

SERIAL

90981354

REG#

7689563

REGISTERED

Feb 11, 2025

Filing Information

StatusREGISTERED

Filing DateMar 23, 2021

Serial Number90981354

Registration No.7689563

Registration DateFeb 11, 2025

Status DateFeb 11, 2025

Published for OppositionJun 21, 2022

Filing Basis & Declarations

Standard Characters ClaimedUse Application CurrentlyTrademark

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 042Scientific, technology & SaaS services

US codes: 100, 101

First use anywhere: Dec 31, 2020

First use in commerce: Dec 31, 2020

This description is as filed with the USPTO and defines the scope of trademark protection.

Run a conflict check

Search by serial number, mark name, or logo. See conflicting marks ranked by risk with clear explanations of what contributed.

Run conflict check

Status History

43 events

REGISTERED-PRINCIPAL REGISTER

Feb 11, 2025

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Feb 11, 2025

NOTICE OF REGISTRATION CONFIRMATION EMAILED

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Jan 21, 2025

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Jan 21, 2025

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

SOU EXTENSION 4 GRANTED

Dec 16, 2024

SOU EXTENSION 4 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Dec 16, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

DIVISIONAL PROCESSING COMPLETE

Dec 16, 2024

DIVISIONAL PROCESSING COMPLETE

STATEMENT OF USE PROCESSING COMPLETE

Dec 16, 2024

STATEMENT OF USE PROCESSING COMPLETE

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 22, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Nov 18, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Oct 23, 2024

CASE ASSIGNED TO INTENT TO USE PARALEGAL

USE AMENDMENT FILED

Aug 19, 2024

USE AMENDMENT FILED

DIVISIONAL REQUEST RECEIVED

Aug 19, 2024

DIVISIONAL REQUEST RECEIVED

TEAS REQUEST TO DIVIDE RECEIVED

Aug 19, 2024

TEAS REQUEST TO DIVIDE RECEIVED

TEAS STATEMENT OF USE RECEIVED

Aug 19, 2024

TEAS STATEMENT OF USE RECEIVED

SOU EXTENSION 4 FILED

Aug 14, 2024

SOU EXTENSION 4 FILED

SOU TEAS EXTENSION RECEIVED

Aug 14, 2024

SOU TEAS EXTENSION RECEIVED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 09, 2024

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 08, 2024

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 3 FILED

Feb 08, 2024

SOU EXTENSION 3 FILED

SOU EXTENSION 3 GRANTED

Feb 08, 2024

SOU EXTENSION 3 GRANTED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Aug 12, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU EXTENSION 2 GRANTED

Aug 10, 2023

SOU EXTENSION 2 GRANTED

SOU TEAS EXTENSION RECEIVED

Aug 10, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 2 FILED

Aug 10, 2023

SOU EXTENSION 2 FILED

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Feb 10, 2023

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

SOU TEAS EXTENSION RECEIVED

Feb 08, 2023

SOU TEAS EXTENSION RECEIVED

SOU EXTENSION 1 FILED

Feb 08, 2023

SOU EXTENSION 1 FILED

SOU EXTENSION 1 GRANTED

Feb 08, 2023

SOU EXTENSION 1 GRANTED

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Aug 16, 2022

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

PUBLISHED FOR OPPOSITION

Jun 21, 2022

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jun 21, 2022

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Jun 01, 2022

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

APPROVED FOR PUB - PRINCIPAL REGISTER

May 19, 2022

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Apr 26, 2022

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Apr 26, 2022

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Apr 26, 2022

TEAS/EMAIL CORRESPONDENCE ENTERED

NON-FINAL ACTION WRITTEN

Oct 28, 2021

NON-FINAL ACTION WRITTEN

NON-FINAL ACTION E-MAILED

Oct 28, 2021

NON-FINAL ACTION E-MAILED

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Oct 28, 2021

NOTIFICATION OF NON-FINAL ACTION E-MAILED

ASSIGNED TO EXAMINER

Oct 27, 2021

ASSIGNED TO EXAMINER

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jun 28, 2021

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

NEW APPLICATION ENTERED

Mar 26, 2021

NEW APPLICATION ENTERED

Other Marks by Scribe Therapeutics Inc.

Additional USPTO filings from the same owner.

SCR

SCRIBE THERAPEUTICS

97420511

Scribe Therapeutics Inc.

REGISTERED

XSC

X SCRIBE THERAPEUTICS

97473474

Scribe Therapeutics Inc.

REGISTERED

SCR

SCRIBE

88188800

Scribe Therapeutics Inc.

REGISTERED

SCR

SCRIBE THERAPEUTICS

50024118

Scribe Therapeutics Inc.

PENDING

Other Marks in Class 042 — Scientific, technology & SaaS services

Recently filed and registered marks in the same international class.

STA

STAR-CRISPR

79426106

Celyntra Therapeutics SA

REGISTERED

CRI

CRISPR THERAPEUTICS

87980024

CRISPR Therapeutics AG

REGISTERED

CRI

CRISPR THERAPEUTICS

87980023

CRISPR Therapeutics AG

REGISTERED

CRI

CRISPR THERAPEUTICS

98164705

CRISPR Therapeutics AG

REGISTERED

Other Marks by John Paul Oleksiuk

Additional USPTO filings handled by the same attorney of record.

BIT

BITTERROOTBIO

98651562

REGISTERED

GEN

GENIES & GEMS

86748978

REGISTERED

AMP

AMPATHY

86761779

REGISTERED

NOT

NOTABLE CAPITAL

98406930

REGISTERED

CRISPR BY DESIGN

Run a conflict check

Other Marks by Scribe Therapeutics Inc.

Other Marks in Class 042 — Scientific, technology & SaaS services

Other Marks by John Paul Oleksiuk

Get pre-filing clearance

Search 15M+ trademarks

Resources

Company